BMC anesthesiology
The most recent articles from:
BMC Anesthesiol
-
The relative efficacy of antiemetics for the treatment of postoperative nausea and vomiting (PONV) is poorly understood. ⋯ Of 100 vomiting surgical patients receiving a 5-HT3 receptor antagonist, 20 to 30 will stop vomiting who would not have done so had they received a placebo; less will profit from the anti-nausea effect. There is a lack of evidence for a clinically relevant dose-response; minimal effective doses may be used. There is a discrepancy between the plethora of trials on prevention of PONV and the paucity of trials on treatment of established symptoms. Valid data on the therapeutic efficacy of classic antiemetics, which have been used for decades, are needed.